The immunomodulatory imide drug class includes thalidomide which has a protein binding of 5565% and has hydrolized metabolites.
The IMiD class includes thalidomide and its analogues (lenalidomide, pomalidomide, iberdomide, and apremilast). Protein binding 5565% Metabolites Hydrolized metabolites 
